325 POSTER Decline in serum HER-2/neu predicts response to trastuzumab-based therapy

Authors :: Francisco J. Esteva
K. Leitzel
D. Luftner
Marie-France Pichon
Wolfgang J. Köstler
Monica Fornier
Allan Lipton
C. Tse
L. Harris
J. Gligorov
Source :: European Journal of Cancer Supplements. 4:102
Publication Year :: 2006
Publisher :: Elsevier BV, 2006.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Her 2 neu
business.industry
Trastuzumab
Internal medicine
Medicine
business
medicine.drug

Full Text Access

Tools